We are live on ! Find out more
Vontobel Holding

Vontobel Holding Portfolio holdings

AUM $29.1B
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+14.18%
1 Year Est. Return
+22.79%
3 Year Est. Return
+78.52%
5 Year Est. Return
+85.53%
10 Year Est. Return
AUM
$11.9B
AUM Growth
+$1.11B
Cap. Flow
-$261M
Cap. Flow %
-2.19%
Top 10 Hldgs %
24.67%
Holding
1,180
New
115
Increased
337
Reduced
532
Closed
80

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$59.8M
2
TSLA icon
Tesla
TSLA
+$51.7M
3
MSFT icon
Microsoft
MSFT
+$49M
4
TJX icon
TJX Companies
TJX
+$35.4M
5
VLTO icon
Veralto
VLTO
+$28.2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$68.9M
2
PDD icon
Pinduoduo
PDD
+$55.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$46.7M
4
AAPL icon
Apple
AAPL
+$44.6M
5
UBS icon
UBS Group
UBS
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 34.14%
2 Healthcare 12.23%
3 Consumer Discretionary 10.73%
4 Industrials 10.69%
5 Financials 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTCI icon
1051
FTC Solar
FTCI
$43.2M
$80.2K ﹤0.01%
11,582
-152
-1% -$1.38K
SIRI icon
1052
SiriusXM
SIRI
$10.7B
$78.2K ﹤0.01%
1,430
DNA icon
1053
Ginkgo Bioworks
DNA
$503M
$76K ﹤0.01%
1,125
ARDX icon
1054
Ardelyx
ARDX
$1.25B
$74.4K ﹤0.01%
+12,000
New +$53.8K
NGD
1055
DELISTED
New Gold Inc
NGD
$72.5K ﹤0.01%
50,000
RVPH
1056
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$72.1K ﹤0.01%
+700
New +$62.8K
UPLD icon
1057
Upland Software
UPLD
$14.4M
$71.9K ﹤0.01%
1,700
OGI
1058
Organigram Holdings
OGI
$134M
$70.5K ﹤0.01%
54,275
-118,549
-69% -$146K
CVM icon
1059
CEL-SCI Corp
CVM
$21M
$68.3K ﹤0.01%
+833
New +$51.9K
ARQT icon
1060
Arcutis Biotherapeutics
ARQT
$3.55B
$67.8K ﹤0.01%
21,000
-28,191
-57% -$76.6K
CMRX
1061
DELISTED
Chimerix, Inc.
CMRX
$67.4K ﹤0.01%
70,000
BKKT icon
1062
Bakkt Inc
BKKT
$334M
$66.9K ﹤0.01%
1,200
DMTK
1063
DELISTED
DermTech, Inc. Common Stock
DMTK
$64.8K ﹤0.01%
37,000
BLNK icon
1064
Blink Charging
BLNK
$74.1M
$58K ﹤0.01%
17,104
-2,979
-15% -$9.3K
ALLO icon
1065
Allogene Therapeutics
ALLO
$573M
$57.8K ﹤0.01%
18,000
+4,000
+29% +$11.3K
WIMI
1066
WiMi Hologram Cloud
WIMI
$21M
$51.9K ﹤0.01%
6,410
+1,581
+33% +$10.7K
CHRS icon
1067
Coherus Oncology
CHRS
$222M
$50K ﹤0.01%
+15,000
New +$40.2K
DADA
1068
DELISTED
Dada Nexus
DADA
$46.6K ﹤0.01%
14,022
+2,441
+21% +$9.01K
ACB
1069
Aurora Cannabis
ACB
$168M
$44.8K ﹤0.01%
+9,135
New +$44.1K
CVAC
1070
DELISTED
CureVac
CVAC
$44.6K ﹤0.01%
+10,584
New +$57.4K
GRAB icon
1071
Grab
GRAB
$14.1B
$43.8K ﹤0.01%
12,999
-126,200
-91% -$408K
RIGL icon
1072
Rigel Pharmaceuticals
RIGL
$712M
$43.5K ﹤0.01%
3,000
KOD icon
1073
Kodiak Sciences
KOD
$2.52B
$42.6K ﹤0.01%
14,000
ATRA icon
1074
Atara Biotherapeutics
ATRA
$70.4M
$41K ﹤0.01%
+3,200
New +$74.6K
NIU
1075
Niu Technologies
NIU
$208M
$39.1K ﹤0.01%
17,843
-3,108
-15% -$7.11K

Similar funds

Vontobel Holding's Q4 2023 Portfolio in Review

As of Q4 2023, Vontobel Holding held 1,180 positions worth $11.9B, up 10% from $10.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Vontobel Holding's Q4 2023 filing shows 115 new, 337 increased, 532 reduced and 80 closed positions. Its largest new stake was Veralto: 377,981 shares worth $31.1M. The largest sale was Procter & Gamble, an estimated $68.9M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Vontobel Holding's largest Q4 2023 buy was Veralto: 377,981 shares worth $31.1M.
  • Vontobel Holding added most to Applied Materials in Q4 2023, an estimated $59.8M increase.
  • Vontobel Holding's biggest Q4 2023 reduction was Procter & Gamble, cutting an estimated $68.9M.
  • Vontobel Holding fully exited American Airlines Group in Q4 2023, selling an estimated $4.39M.
  • Vontobel Holding's ten largest holdings make up 25% of its $11.9B portfolio in Q4 2023.
  • Vontobel Holding opened 115 new positions and closed 80 in Q4 2023.
  • Vontobel Holding's portfolio value rose 10% quarter-over-quarter to $11.9B.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.